Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 2
1977 5
1978 11
1979 14
1980 17
1981 26
1982 47
1983 44
1984 83
1985 57
1986 62
1987 51
1988 49
1989 43
1990 27
1991 44
1992 41
1993 28
1994 37
1995 26
1996 33
1997 29
1998 25
1999 35
2000 23
2001 21
2002 33
2003 23
2004 30
2005 37
2006 30
2007 26
2008 29
2009 25
2010 34
2011 34
2012 31
2013 21
2014 29
2015 29
2016 31
2017 25
2018 21
2019 23
2020 38
2021 33
2022 17
2023 20
2024 30
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,441 results

Results by year

Filters applied: . Clear all
Page 1
Noninferiority and Safety of Nadolol vs Propranolol in Infants With Infantile Hemangioma: A Randomized Clinical Trial.
Pope E, Lara-Corrales I, Sibbald C, Liy-Wong C, Kanigsberg N, Drolet B, Ma J. Pope E, et al. JAMA Pediatr. 2022 Jan 1;176(1):34-41. doi: 10.1001/jamapediatrics.2021.4565. JAMA Pediatr. 2022. PMID: 34747977 Free PMC article. Clinical Trial.
However, other less lipophilic beta-blockers, such as nadolol, may be preferable in individuals who experience propranolol unresponsiveness or adverse events. OBJECTIVE: To document the noninferiority and safety of oral nadolol compared with oral propranolol in infa …
However, other less lipophilic beta-blockers, such as nadolol, may be preferable in individuals who experience propranolol unresponsi …
Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices.
Zacharias AP, Jeyaraj R, Hobolth L, Bendtsen F, Gluud LL, Morgan MY. Zacharias AP, et al. Cochrane Database Syst Rev. 2018 Oct 29;10(10):CD011510. doi: 10.1002/14651858.CD011510.pub2. Cochrane Database Syst Rev. 2018. PMID: 30372514 Free PMC article. Review.
The intervention comparisons were carvedilol versus propranolol (nine trials), or nadolol (one trial). Six trials were of short duration (mean 6 (range 1 to 12) weeks), while four were of longer duration (13.5 (6 to 30) months). ...Sixteen of 254 participants receiving car …
The intervention comparisons were carvedilol versus propranolol (nine trials), or nadolol (one trial). Six trials were of short durat …
Primary prophylaxis of variceal bleeding.
Robertson M, Hayes P. Robertson M, et al. Hepatol Int. 2018 Jan;12(1):1-5. doi: 10.1007/s12072-018-9846-1. Epub 2018 Feb 2. Hepatol Int. 2018. PMID: 29396732 No abstract available.
Outcomes of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia Treated With β-Blockers.
Mazzanti A, Kukavica D, Trancuccio A, Memmi M, Bloise R, Gambelli P, Marino M, Ortíz-Genga M, Morini M, Monteforte N, Giordano U, Keegan R, Tomasi L, Anastasakis A, Davis AM, Shimizu W, Blom NA, Santiago DJ, Napolitano C, Monserrat L, Priori SG. Mazzanti A, et al. JAMA Cardiol. 2022 May 1;7(5):504-512. doi: 10.1001/jamacardio.2022.0219. JAMA Cardiol. 2022. PMID: 35353122 Free PMC article.
The risk of LTAE among those taking selective beta-blockers vs nadolol was increased 6-fold (HR, 5.8; 95% CI, 2.1-16.3; P = .001). Conversely, no significant difference was present between propranolol and nadolol (HR, 1.8; 95% CI, 0.4-7.3; P = .44). ...CONCLUSIONS A …
The risk of LTAE among those taking selective beta-blockers vs nadolol was increased 6-fold (HR, 5.8; 95% CI, 2.1-16.3; P = .001). Co …
Clinical pharmacokinetics of nadolol: A systematic review.
Kalsoom S, Zamir A, Rehman AU, Ashraf W, Imran I, Saeed H, Majeed A, Alqahtani F, Rasool MF. Kalsoom S, et al. J Clin Pharm Ther. 2022 Oct;47(10):1506-1516. doi: 10.1111/jcpt.13764. Epub 2022 Aug 30. J Clin Pharm Ther. 2022. PMID: 36040016 Review.
The bioavailability of nadolol was greatly reduced by the coadministration of green tea. Nadolol can be effectively removed by hemodialysis. ...WHAT IS NEW AND CONCLUSION: Since, there is no previous report of a systematic review on the PK of nadolol, the cur …
The bioavailability of nadolol was greatly reduced by the coadministration of green tea. Nadolol can be effectively removed by …
[Beta-blockers and migraine].
Massiou H, Bousser MG. Massiou H, et al. Pathol Biol (Paris). 1992 Apr;40(4):373-80. Pathol Biol (Paris). 1992. PMID: 1353872 Review. French.
Five beta-blocking agents are effective as long-term prophylactic treatment of migraine: propranolol, metoprolol, timolol, atenolol and nadolol. Propranolol has been most extensively studied and proved effective in 19 of 21 controlled trials. ...
Five beta-blocking agents are effective as long-term prophylactic treatment of migraine: propranolol, metoprolol, timolol, atenolol and n
Long QT syndrome.
Abrams DJ, Macrae CA. Abrams DJ, et al. Circulation. 2014 Apr 8;129(14):1524-9. doi: 10.1161/CIRCULATIONAHA.113.003985. Circulation. 2014. PMID: 24709866 No abstract available.
Hypothyroidism-induced bradycardia.
Ahmad S. Ahmad S. J Fam Pract. 1995 Nov;41(5):432-3. J Fam Pract. 1995. PMID: 7595253 No abstract available.
Pseudopheochromocytoma.
Kuchel O. Kuchel O. Hypertension. 1985 Jan-Feb;7(1):151-8. doi: 10.1161/01.hyp.7.1.151. Hypertension. 1985. PMID: 3980057 No abstract available.
1,441 results